DME Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.3M | Buy |
3,778,777
+3,210,577
| +565% | +$53.8M | 2.72% | 12 |
|
|
2025
Q1 | $8.73M | Buy |
568,200
+99,650
| +21% | +$1.53M | 0.44% | 23 |
|
|
2024
Q4 | $10.3M | Buy |
468,550
+143,700
| +44% | +$3.17M | 0.53% | 22 |
|
|
2024
Q3 | $5.85M | Hold |
324,850
| – | – | 0.24% | 28 |
|
|
2024
Q2 | $5.28M | Hold |
324,850
| – | – | 0.26% | 27 |
|
|
2024
Q1 | $4.58M | Buy |
+324,850
| New | +$4.58M | 0.21% | 29 |
|